Leveraging Research Failures to Accelerate Drug Discovery and Development

Research failures are one of the most significant costs associated with the estimated USD2.6 billion price tag and 12-year time frame to bring a drug from discovery to market. The European Commission estimates that USD0 billion are spent every year to develop innovations that have already developed elsewhere, highlighting the exorbitant cost of duplication. The competitive nature of the pharmaceutical industry is such that the voluntary...